Pharma-Bio Serv, Inc. (PBSV)
Pharma-Bio Serv, Inc. (PBSV)
| Balance Sheets | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 |
|---|---|---|---|---|
| Cash and cash equivalents | 1,791,474 | 5,763,618 | 3,379,212 | 3,957,752 |
| Marketable securities | 6,680,834 | 4,796,568 | 7,475,377 | 6,767,282 |
| Accounts receivable | 2,723,404 | 2,654,675 | 2,360,682 | 2,015,529 |
| Prepaids and other assets | 90,560 | 109,108 | 171,574 | 415,093 |
| Total current assets | 11,286,272 | 13,323,969 | 13,386,845 | 13,155,656 |
| Property and equipment, net | 92,355 | 103,674 | 116,059 | 131,526 |
| Operating lease right-of-use | 0 | 0 | 29,388 | 72,747 |
| Other assets | 120,771 | 120,783 | 120,754 | 225,649 |
| Total assets | 11,499,398 | 13,548,426 | 13,653,046 | 13,585,578 |
| Current operating lease liabilities | 0 | 0 | 28,834 | 71,362 |
| Accounts payable and accrued expenses | 978,541 | 869,964 | 991,169 | 874,379 |
| Dividend payable to shareholders | NaN | 1,717,627 | NaN | NaN |
| Current portion of us tax reform transition tax and income taxes payable | 66,628 | 722,104 | 718,796 | 713,153 |
| Total current liabilities | 1,045,169 | 3,309,695 | 1,738,799 | 1,658,894 |
| Us tcja transition tax payable | NaN | NaN | 0 | 0 |
| Long term operating lease liabilities | NaN | NaN | 0 | 0 |
| Total liabilities | 1,045,169 | 3,309,695 | 1,738,799 | 1,658,894 |
| Common stock, 0.0001 par value authorized 50,000,000 shares 23,519,672 and 23,519,672 shares issued, and 22,901,692 and 22,905,992 shares outstanding at april 30, 2026 and october 31, 2025, respectively | 2,352 | 2,352 | 2,352 | 2,352 |
| Additional paid-in capital | 1,696,785 | 1,688,166 | 1,679,547 | 1,675,148 |
| Retained earnings | 9,081,808 | 8,848,822 | 10,533,589 | 10,533,691 |
| Accumulated other comprehensive income | 254,960 | 280,358 | 278,045 | 285,577 |
| Stockholders' equity before treasury stock | 11,035,905 | 10,819,698 | 12,493,533 | NaN |
| Treasury stock, at cost 613,680 and 561,529 common shares held on october 31, 2025 and 2024, respectively | NaN | NaN | 579,286 | NaN |
| Treasury stock, at cost 617,980 and 613,680 common shares held at april 30, 2026 and october 31, 2025, respectively | 581,676 | 580,967 | NaN | 570,084 |
| Total stockholders' equity | 10,454,229 | 10,238,731 | 11,914,247 | 11,926,684 |
| Total liabilities and stockholders' equity | 11,499,398 | 13,548,426 | 13,653,046 | 13,585,578 |